The Brn-3 family of POU (Pit-Oct-Unc) homeodomain transcription factors regulate differentiation of neuronal cell types. The transcriptional activator Brn-3a is expressed in Ewing's sarcomas, which also express characteristic chimaeric proteins as a consequence of fusion of the TET family gene EWS to one of several ETS genes. We have previously demonstrated a physical interaction between Brn-3a and EWS proteins, and show here that the C-terminal POU domain but not N-terminal activation domain of Brn-3a can interact in vitro with the RNA-binding domain of EWS. Likely due to POU domain homology, the related factor Brn-3b can also interact with EWS, but to a lesser extent than Brn-3a. Importantly, Brn-3a but not Brn-3b interacts in vitro with chimaeric EWS/Fli-1, EWS/ATF-1 and EWS/ERG proteins. Furthermore, overexpression of EWS/Fli-1 but not EWS or Fli-1 inhibits Brn-3a-associated growth arrest and neurite outgrowth in neuronal cells, and specifically inhibits Brn-3a-dependent activation of p21 and SNAP-25 transcription. In contrast, upregulation of Bcl-2 expression and inhibition of apoptosis by Brn-3a is antagonized more by EWS than by EWS/Fli-1. These data demonstrate that oncogenic rearrangement of EWS to produce EWS/Fli-1 may enhance the antiapoptotic effect of Brn3a and inhibit its ability to promote neuronal differentiation.
Introduction
Transcription factors containing the POU (Pit-Oct-Unc) domain are widely involved in regulation of vertebrate development (Andersen and Rosenfeld, 1994) . Specifically, the Brn-3 POU proteins Brn-3a, Brn-3b and Brn3c are critically required for differentiation of specific neuronal lineages McEvilly et al., 1996; Xiang et al., 1996; Huang et al., 1999) . While expression of Brn-3a is associated with differentiation of sensory neurons, Brn-3b expression decreases in differentiated cells (Lillycrop et al., 1992) . These inverse expression patterns mirror antagonistic effects on promoters of genes encoding proteins associated with neuronal differentiation such as SNAP-25 and neurofilaments (Lakin et al., 1995; Smith et al., 1997) , with Brn-3a generally being a transcriptional activator and Brn-3b a repressor. Importantly, Brn-3a induces differentiation and inhibits apoptosis in neuronal cells when overexpressed (Smith et al., 1997 (Smith et al., , 1998 Ensor et al., 2001) . Brn-3a can cooperate with Ras to transform primary rat fibroblasts (Theil et al., 1993) , and roles for Brn-3 proteins in oncogenesis are also suggested by their aberrant expression in cervical cancer cells and breast cancer cells . Significantly, Brn-3a is expressed in cancer cells of neuronal lineage, in some neuroblastomas (Smith and Latchman, 1996) and in Ewing's sarcoma cells (Collum et al., 1992; Frass et al., 2002) .
Ewing's tumour cells are characterized by their small round morphology, and at the molecular level by gene fusions between EWS, a member of the TET family, and members of the ETS family . Specifically, EWS/Fli-1 translocation is exhibited by approximately 80% of Ewing's tumours. Wild-type EWS has an RNA-binding domain and may be involved in RNA processing (Ohno et al., 1994) , but may also regulate transcription (Li and Lee, 2000; Rossow and Janknecht, 2001 ). In contrast, ETS proteins such as Fli-1 are sequence-specific DNA-binding transcription factors (Sharrocks, 2001) . EWS/ETS fusion proteins such as EWS/Fli-1, which contain the N-terminal activation domain of EWS and the C-terminal ETS DNA-binding domain, are sufficient to transform NIH-3T3 cells (May et al., 1993; Thompson et al., 1999) . Furthermore, ablation of fusion transcript expression inhibits growth of Ewing's tumour cells (Ouchida et al., 1995) , suggesting critical roles of EWS/ETS fusion proteins for both tumour initiation and maintenance.
The mechanisms by which EWS/ETS fusion proteins contribute to oncogenesis remain not entirely understood. The EWS N-terminus is more transcriptionally active than the ETS N-terminus, thus fusion results in aberrant activation of ETS-responsive promoters (May et al., 1993; Bailly et al., 1994; Mao et al., 1994) . However, EWS/Fli-1 can activate oncogenic signaling pathways in the absence of an intact ETS DNA-binding domain (Jaishankar et al., 1999; Welford et al., 2001) and EWS/Fli-1 and Fli-1 have distinct target gene profiles (Braun et al., 1995; Nishimori et al., 2002) , suggesting that EWS/Fli-1 may be recruited to DNA via ETS-independent mechanisms. In this regard, interactions of EWS and EWS/Fli-1 with the basal transcription machinery have been identified (Bertolotti et al., 1998; Petermann et al., 1998; Yang et al., 2000) , and EWS can interact with the transcriptional coactivators CBP/p300 to mediate transcription of distinct genes in some cell types (Rossow and Janknecht, 2001 ). In addition, it is likely that oncogenesis driven by EWS/ ETS fusion proteins requires aberrant transcriptional regulation mediated via interactions with sequencespecific transcription factors. Transcriptional repression of TGF-b RII is an important target of EWS fusions in oncogenesis (Hahm et al., 1999; Im et al., 2000) , and EWS/Fli-1 can also regulate alternative splicing of premRNA (Chansky et al., 2001) .
Using a yeast two-hybrid screen, we have recently identified a physical interaction between Brn-3a and wild-type EWS proteins (Thomas and Latchman, 2002) , and have shown that EWS/Fli-1 may also interact with Brn-3a. Here, in order to further understand the mechanism by which EWS and EWS/Fli-1 interact with Brn-3a, the domains responsible for interaction have been identified in vitro. Furthermore, binding of the related Brn-3b protein to EWS has been demonstrated. Interactions of Brn-3 proteins with another RNAbinding TET family member, TLS, and with additional EWS/ETS fusion proteins have also been identified. Importantly, EWS/Fli-1, but not wild-type EWS or Fli-1, antagonizes differentiation-induced growth arrest and Brn-3a-dependent neurite outgrowth, while Brn-3a-dependent inhibition of apoptosis is inhibited by EWS but not EWS/Fli-1.
Results

EWS interacts with the POU domain but not the N-terminal activation domain of Brn-3 proteins
In order to determine the domain(s) of Brn-3a required for interaction with EWS, experiments were performed using the GST proteins illustrated in Figure 1a . Fulllength Brn-3a bound strongly to wild-type EWS, while the N-terminus of Brn-3a alone was insufficient to mediate interaction (Figure 1b) . In contrast, the isolated POU domain of Brn-3a interacted with EWS. Interestingly, EWS also bound to Brn-3b and to its isolated POU domain (Figure 1b) , although the interaction with Brn-3b was weaker than with Brn-3a. EWS can bind RNA in vitro (Ohno et al., 1994) , thus it was necessary to understand if contaminating nucleic acid in these assays might mediate interaction with Brn-3 proteins. Importantly, when an excess of ethidium bromide was added to the samples to sequester contaminating nucleic acid, interactions remained (Figure 1c) . While the binding of EWS to Brn-3b was unaltered by ethidium bromide, binding to Brn-3a was slightly reduced, indicating that interactions of EWS with Brn-3a may be strengthened by nucleic acid.
Brn-3 proteins interact with the C-terminal RNA-binding domain of EWS
To determine the domain(s) of EWS required for interaction with Brn-3 proteins, GST pulldown assays Figure 1 Interactions between EWS protein and Brn-3 domains in vitro. (a) GST fusion proteins containing Brn-3 domains were purified from Escherichia coli using glutathione beads. Domains of Brn-3 are indicated I-IV, homologous N-terminal activation domains are shaded, C-terminal activation domains are shown striped, amino-acid numbering as per murine sequence. (b) GST pulldown assay demonstrating interactions of full-length EWS with full-length and POU domain Brn-3 proteins. Radiolabelled EWS and luciferase were incubated with equal amounts of GST-Brn-3 proteins immobilized on glutathione beads, and after extensive washes, bound proteins were recovered from glutathione/Brn-3 beads by boiling and analysed by SDS-PAGE. GST-Brn-3a protein interacted strongly with EWS, while GST-Brn-3b protein and proteins containing the isolated Brn-3 POU domains also interacted. GST-Brn-3 proteins did not interact with luciferase, demonstrating specificity of EWS interactions. Molecular weights are indicated at right in kDa. (c) GST pulldown assay demonstrating interaction of full-length EWS with Brn-3 proteins in the absence of nucleic acid. Assays were performed as in (b) but in the presence of 50 mg ethidium bromide per sample. Interactions were maintained in the presence of ethidium bromide, although interaction of EWS with Brn-3a but not Brn-3b was reduced. Molecular weights are indicated at right in kDa Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al were performed using the in vitro translated proteins shown in Figure 2a . Interaction with Brn-3a and Brn-3b was exhibited by EWS(247-656) and EWS(386-656), which contain the RNA-binding EWS C-terminus, but not by the N-terminal proteins EWS(1-246) and EWS(1-345) (Figure 2b ). Full-length EWS and EWS(247-656) demonstrated more binding to Brn-3a than to Brn-3b (Figures 1b and 2b) , while EWS(386-656) bound more to Brn-3b than Brn-3a, suggesting that amino acids 247-385 of EWS may be important for interaction with Brn-3 proteins.
Brn-3 proteins interact with another TET family member TLS, and with EWS in vivo EWS, together with FUS/TLS and TAF II 68, belongs to the TET family of proteins, which have homologies within their C-terminal RNA-binding domains (Bertolotti et al., 1996) . In order to confirm interaction of the EWS C-terminus with Brn-3a, a GST pulldown experiment was performed in the opposite orientation, using GST-EWS(C) and in vitro translated Brn-3a. Again, the EWS C-terminus bound specifically to Brn-3a, as did the C-terminus of TLS (Figure 3a) . Interaction of Brn-3 proteins with TLS was confirmed using GST-Brn-3 proteins and radiolabelled TLS (Figure 3b ). Importantly, GST-EWS(C) and GST-TLS(C) were also able to specifically bind FLAG-tagged Brn-3a expressed in transfected COS-7 cells (Figure 3c ) and Brn-3a stably overexpressed in IMR-32 neuroblastoma cells (Figure 3d ). Hence, EWS and TLS can bind specifically to Brn-3a in extracts of total cellular protein. In the latter experiment, membranes were probed for STAT-1 as a control, and while there was no interaction between EWS and STAT-1, TLS showed a weak interaction with Figure 2 Interactions between Brn-3 proteins and EWS domains in vitro. (a) EWS domains as shown were transcribed and translated in vitro. RGG motifs and RNA-binding domain are indicated, N-terminal activation domain is shaded, amino-acid numbering as per human sequence. (b) GST pulldown assay demonstrating interaction of full-length Brn-3a and Brn-3b with the C-terminus but not the N-terminus of EWS. GST-Brn-3a and GST-Brn-3b as shown in Figure 1 were incubated with radiolabelled EWS proteins as shown in (a). Multiple bands in EWS (247-656) and EWS (386-656) protein preparations are likely to result from initiation of translation at internal start sites. Molecular weights are indicated at right in kDa Figure 1 were incubated with radiolabelled full-length TLS protein, and showed binding which was not exhibited by GST alone. (c) COS-7 cells were transfected with pSG5-FLAG-3aL and incubated 36 h to enable tagged protein expression. Purified GST proteins as used in (a) were incubated with equal amounts of whole-cell lysate from transfected cells, and proteins bound to GST beads were analysed by SDS-PAGE and immunoblot for FLAG-tagged proteins. Greater than 20% of tagged Brn-3a protein bound to both EWS and TLS C-termini, while binding to GST alone was minimal. (d) A similar experiment to that performed in (c), using whole-cell lysate of IMR-32 cells stably expressing Brn-3a and their vector controls. Specific interactions of Brn-3a with TET C-termini are demonstrated, and are compared to the minimal interaction with STAT-1. (e) COS-7 cells were transfected with pSG5 or pSG5-FLAG-3aL and cultured for 36 h. Nuclear lysates were prepared, 10% of each lysate retained as 'input' sample, and FLAG-tagged protein complexes immunoprecipitated from the remaining 90% lysate. After SDS-PAGE, expression and efficient purification of Brn-3a was confirmed by immunoblot for FLAG-tagged proteins, and presence of EWS in Brn-3a complexes identified by immunoblot for EWS Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al STAT-1 in cells transfected with or without Brn-3a. However, this interaction was significantly less than that between either EWS or TLS and Brn-3a. In order to examine in vivo interactions, Brn-3a-containing protein complexes were immunoprecipitated from transfected COS-7 cells and analysed for presence of EWS by immunoblot analysis. Importantly, small amounts of EWS were reproducibly present in immunoprecipitates from cells transfected with Brn-3a but not in those from cells transfected with vector alone (Figure 3e ).
Brn-3a but not Brn-3b interacts with EWS/ETS fusion proteins via the ETS domain
Expression of Brn-3a has been demonstrated in Ewing's sarcoma samples (Collum et al., 1992) and recently in a Ewing's sarcoma cell line (Frass et al., 2002) . Identification of the EWS C-terminus as the domain required for interaction with Brn-3 proteins suggested that EWS fusion proteins might not interact with Brn-3 proteins since they lack the C-terminal domain of EWS. However, the EWS/ETS proteins EWS/Fli-1, EWS/ ERG, EWS/ETV1, and also EWS/ATF-1 ( Figure 4a ) can interact significantly with Brn-3a but not Brn-3b in vitro ( Figure 4b ). While GST-Brn-3a beads retained approximately 10% of wild-type EWS in these assays (Figures 1b and c), GST-Brn-3a beads bound less than 3% of available EWS fusion proteins (Figure 4b ), suggesting that interactions of Brn-3 proteins with EWS and EWS fusion proteins are quantitatively and qualitatively distinct. As with wild-type EWS (Figure 1b ), EWS/Fli-1 was able to bind the isolated POU domain of Brn-3a (Figure 4b ). In order to determine whether Brn-3a might bind to EWS/Fli-1 via its C-terminal Fli-1 sequences, interaction experiments were performed with full-length and truncated Fli-1 proteins (Figure 4c ). Full-length human Fli-1 binds to GST-Brn-3a but not to GST-Brn-3b (Figure 4d ), a similar interaction profile to that exhibited by EWS/Fli-1. As anticipated, the isolated C-terminal domain but not the N-terminal domain of Fli-1 was able to bind GST-Brn-3a (Figure 4d ), providing evidence that interactions of EWS fusion proteins with Brn-3a are likely to be mediated, at least in part, by the C-terminal domain of the chimaera. , 2002) . Expression of p21 is low in Ewing's tumours and treatment with antisense EWS/Fli-1 oligonucleotides increases p21 expression in Ewing's sarcoma cells (Matsumoto et al., 2001) . Thus, we investigated the effects of EWS/Fli-1 on Brn-3a-dependent p21 expression and cell cycle arrest in neuronal ND7 cells. In contrast to the Bcl-x promoter where EWS but not EWS/Fli-1 represses Brn-3a-dependent effects (Thomas and Latchman, 2002) , regulation of p21 promoter activity by Brn-3a was observed in the presence of vector, EWS, or Fli-1 (Po0.01) but not in the presence of EWS/Fli-1 (Figures  5a and b) . Activation of the p21 promoter by the isolated POU domain was also specifically inhibited by EWS/Fli-1 (Figure 5c ), correlated with the interaction studies indicating that EWS/Fli-1 interacts with the POU domain of Brn-3a (Figure 4b ). The ability of EWS/Fli-1 to specifically inhibit Brn3a-dependent p21 promoter activity suggested that differentiation-induced growth arrest associated with Brn-3a expression might also be inhibited by EWS/Fli-1. Correlated with previous Brn-3a transcript analysis (Lillycrop et al., 1992) , expression of Brn-3a protein was increased in ND7 cells treated with differentiation medium for 48 h (Figure 5d ). Differentiation was associated with an increased percentage of cells at G1 and a decreased percentage of cells in S and G2 phases in cultures transfected with vector alone (Figures 5e and f) . Importantly, overexpression of EWS/Fli-1 almost completely abolished the differentiation-associated growth arrest, while overexpression of either EWS or Fli-1 alone had limited ability to do so (Figures 5e and f) .
EWS/Fli-1 inhibits Brn-3a-dependent SNAP-25 expression and neurite outgrowth
The ability of EWS/Fli-1 to inhibit Brn-3a-dependent p21 transcription and associated growth arrest suggested that this chimaeric protein might inhibit additional aspects of neuronal differentiation by regulating Brn-3a function. Brn-3a promotes expression of SNAP-25 and induces neurite outgrowth in neuronal cells (Lakin et al., 1995; Smith et al., 1997) . In order to investigate further the effect of EWS/Fli-1 on Brn-3a function in neuronal cells, SNAP-25 expression and neurite outgrowth were studied in cotransfection experiments with ND7 cells. Brn-3a-dependent increases in SNAP-25 promoter activity were observed in the presence of vector EWS or Fli-1 (Po0.01) but not in the presence of EWS/Fli-1 (Figure 6a) . Importantly, cells overexpressing EWS or Fli-1 exhibited increased endogenous SNAP-25 protein expression in response to differentiation as did cells transfected with vector alone, while cells expressing EWS/Fli-1 did not (Figure 6b) . Furthermore, neurite outgrowth from ND7 cells induced by Brn-3a was reduced by overexpression of EWS/Fli-1 but not EWS alone (Figure 6d) , and in similar experiments neurite outgrowth induced by lowserum differentiation medium was also inhibited by EWS/Fli-1 but not by EWS or Fli-1 (DMG, data not shown).
Inhibition of apoptosis by Brn-3a is prevented by EWS
Brn-3a not only promotes growth arrest and differentiation but also inhibits apoptosis in sensory neurons , associated with increased transcription of antiapoptotic Bcl-2 and Bcl-x (Smith et al., 1998 . We have previously shown that Bcl-x promoter activity induced by Brn-3a can be inhibited by EWS but not by EWS/Fli-1 ( Thomas and Latchman, 2002) . In order to investigate whether such an effect could be observed on Brn-3a-dependent Bcl-2 expression, immunoblot analysis of transiently transfected ND7 cells was performed (Figure 7a ). In accordance with effects on Bcl-x, EWS but less so EWS/Fli-1 inhibited Brn-3a-induced Bcl-2 expression. These results indicated that EWS but not EWS/Fli-1 might antagonize the antiapoptotic effect of Brn-3a in neuronal cells. Apoptosis induced in ND7 cell cultures by serum deprivation was then determined by TUNEL staining, and it was observed that cells overexpressing Brn-3a alone had an approximate 50% reduction in the level of apoptosis compared with controls (P ¼ 0.001) (Figure 7b ). Interestingly, this antiapoptotic effect was still observed in the presence of EWS/Fli-1 or Fli-1 (Po0.01) but not in the presence of EWS (P ¼ 0.51) (Figure 7b ). Thus, distinct effects of EWS and EWS/Fli-1 on regulation of Bcl-2 and Bcl-x by Brn-3a correlate with selective abilities to antagonize Brn-3a-dependent inhibition of apoptosis.
Two EWS isoforms are expressed in ND7 cells and interact differently with Brn-3a
In order to determine why exogenous EWS expression was able to regulate apoptosis in ND7 cells, which are likely to express high endogenous levels of the ubiquitous EWS protein, immunoblot analysis of EWS expression in ND7 cells was performed. As previously demonstrated in SKSH-5Y cells ), ND7 cells express both isoA and isoN EWS isoforms, which differ in mobility on SDS-PAGE due to an eight amino-acid insertion within isoN (Figure 8a ). We therefore hypothesized that if these EWS isoforms interact differently with Brn-3a, exogenous EWS-isoA might regulate Brn-3a function by altering the Brn-3a/ isoA/isoN balance present in ND7 cells. Interestingly, we found that this was indeed the case; EWS-isoN interactions with Brn-3a in vitro are significantly weaker than those between EWS-isoA and Brn-3a (P ¼ 0.026) (Figure 8b , quantitated in Figure 8c ). Additionally, as the two EWS isoforms differ within the N-terminal activation domain, these results indicate potential importance of this domain, in cooperation with the C-terminal RNA-binding domain, for interactions with POU proteins.
Discussion
Transcriptional targets of EWS/ETS fusion proteins are distinct from those of the corresponding ETS proteins
Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al (Nishimori et al., 2002) , and altered EWS/Fli-1 proteins unable to bind ETS-responsive sequences retain some transforming capacity (Welford et al., 2001) . This indicates that EWS/ETS fusion proteins may be recruited to target promoters via interactions with other transcription factors. We have demonstrated that the POU domain of the Brn-3a transcription factor can bind to both the EWS C-terminus and EWS/ETS fusion proteins in vitro, and that EWS can interact with Brn-3a in mammalian cells. While full-length EWS can interact with both Brn-3a and Brn-3b, EWS/Fli-1, EWS/ERG, and EWS/ETV1 which lack the EWS C-terminus , 1998) , suggesting that conformation of the EWS N-terminus is dependent upon the Cterminus to which it is linked. Thus in addition, the EWS N-terminus may facilitate interaction with Brn-3 proteins not in isolation, but only in the presence of the EWS or ETS C-terminus. In this regard, it is interesting to note that EWS-isoA and neuron-specific EWS-isoN, which vary only within the EWS N-terminal domain , interact differently with Brn-3 proteins. Importantly, interaction of Brn-3a with EWS/Fli-1 has distinct consequences for regulation of neuronal differentiation in transformed sensory neuronal cells. A recent study has identified p21WAF1/CIP1 as a direct transcriptional target of EWS/Fli-1, with repression being mediated via ETS-binding sites in the p21 promoter (Nakatani et al., 2003) . We have shown that EWS/Fli-1 but not EWS can inhibit Brn-3a-dependent but not basal p21 promoter activity in neuronal cells, providing an additional mechanism by which EWS fusion proteins may reduce expression of p21 in Ewing's sarcoma . Importantly, we have correlated EWS/Fli-1-dependent inhibition of p21 with Figure 6 EWS/Fli-1 specifically inhibits Brn-3a-dependent SNAP-25 transcription and neurite outgrowth. (a) ND-7 cells were cotransfected with pJ4 (vector) or pJ4-Brn-3aL (Brn-3a) as in Figure 5a , together with a luciferase reporter containing 2200 bp of the SNAP-25 promoter and pJ4 (vector), pJ4-EWS, pJ4-EWS/Fli-1, or pJ4-Fli-1. Expression of EWS/Fli-1 was uniquely able to inhibit Brn-3a-dependent SNAP-25 promoter activity. (b) ND7 cells were transfected as indicated with pJ4 (vector), pJ4-EWS/Fli-1, pJ4-EWS, or pJ4-Fli-1, duplicates cultured in normal growth medium (À) or differentiation medium to induce Brn-3a expression ( þ ) and SNAP-25 and actin immunoblot analysis were performed. Expression of EWS/Fli-1 was uniquely able to prevent differentiation-induced SNAP-25 expression. (c) ND7 cells were cotransfected with pEGFP-C1 plus pJ4 (vector) or pJ4-Brn-3aL (Brn-3a), and either pJ4, pJ4-EWS, or pJ4-EWS/Fli-1, and cultured for 48 h posttransfection. Transfected cells expressing GFP were scored positive or negative for neurite outgrowth by visual determination Figure 7 EWS but not EWS/Fli-1 inhibits the antiapoptotic effect of Brn-3a in neuronal cells. (a) ND7 cells were transfected with 3 mg pJ4(À) or pJ4-Brn-3aL( þ ), plus 2 mg either pJ4 (vector), pJ4-EWS, or pJ4-EWS/Fli-1 and cultured for 36 h post-transfection. Immunoblot analysis of Bcl-2, Brn-3a ,and actin was then performed. EWS but less so EWS/Fli-1 prevented Brn-3a-dependent increases in Bcl-2 expression. (b) ND7 cells were cotransfected with 0.3 mg pEGFP-C1 plus 0.35 mg pJ4 (vector) or pJ4-Brn-3aL (Brn-3a), and 0.35 mg either pJ4, pJ4-EWS, pJ4-EWS/Fli-1, or pJ4-Fli-1, cultured in serum-free L15 medium for 48 h post-transfection, and DNA fragmentation indicative of apoptosis was measured by rhodamine-TUNEL assay (Roche Dignostics) of GFP-positive transfected cells. EWS but not EWS/Fli-1 or Fli-1 inhibited a Brn-3a-dependent decrease in apoptosis Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al inability to undergo growth arrest in neuronal cells. In addition, EWS/Fli-1 inhibits Brn-3a-dependent SNAP-25 promoter activity and neurite outgrowth. These data provide evidence to support the hypothesis that while EWS/Fli-1 causes growth arrest of primary cells (Lessnick et al., 2002) , expression in transformed cells promotes growth and inhibits differentiation (Eliazer et al., 2003) . In apparent contrast, EWS/ETS fusion proteins induce some aspects of neuronal differentiation in transformed fibroblasts . However, it is possible that EWS/ETS proteins induce a semineuronal but proliferative cellular phenotype, with some aspects of differentiation being inhibited while others promoted. Expression of EWS/Fli-1 in immortalized cells such as 3T3 fibroblasts can inhibit apoptosis (Yi et al., 1997) . Our studies have shown that EWS/Fli-1 has less ability than EWS to decrease Brn-3a-dependent expression of the antiapoptotic Bcl-2 and Bcl-x genes, providing further evidence that expression of EWS fusion proteins is condusive to inhibition of apoptosis. Interestingly, induction of SNAP-25 expression, p21 promoter activity, and neurite outgrowth by Brn-3a can be mediated by the isolated POU domain (Morris et al., 1997; Smith et al., 1997; Perez-Sanchez et al., 2002) , while regulation of Bcl-2 expression and apoptosis by Brn-3a requires its N-terminal domain (Smith et al., 1998) . Thus results presented here, which show different effects of EWS and EWS/Fli-1 on Brn-3a-dependent activation functions, are compatible with direct but distinct physical interactions in vivo.
As previously reported in neuroblastoma cells (Hahm et al., 1999) , the activity of a luciferase reporter containing a TGF-b RII promoter fragment is repressed by EWS/Fli-1 when cotransfected into ND7 cells (DMG, data not shown). However, Brn-3a has no effect upon this repression, suggesting that POU-responsive genes are the main targets of the POU-EWS/ETS interaction. Importantly, the POU domain within Brn3a is conserved across a family of homeodomain proteins which regulate cell fate (Andersen and Rosenfeld, 1994) and thus EWS/ETS fusions may inhibit differentiation by interacting with multiple POU proteins. Brn-3a is expressed in Ewing's sarcoma (Collum et al., 1992) , and a recent study by Wagner et al. (2003) has identified Brn-3b as a transcriptional target of WT-1, which is fused to the EWS N-terminus in desmoplastic small round cell tumours (DSRCT). It may therefore prove interesting to study the effects of EWS fusion proteins on expression of Brn-3 proteins in cells of neuronal origin.
In summary, the studies presented here provide further insight into aberrant transcriptional regulation in Ewing's sarcoma, and identify inhibition of Brn-3a-associated neuronal differentiation to be a consequence of EWS/Fli-1 expression. Inhibition of neuronal differentiation and apoptosis by EWS/Fli-1 protein, at least in part via regulation of POU domain protein function, provides a further mechanism by which chromosomal fusions of EWS and ETS genes promote oncogenesis.
Materials and methods
Mammalian cell culture
Immortalized sensory neuronal ND7 cells (Wood et al., 1990) were cultured as described previously (Thomas and Latchman, 2002) in L15 medium (Gibco) supplemented with 5% foetal bovine serum (Sigma), 0.35% glucose, 0.35% sodium bicarbonate, and 200 mM L-glutamine. COS-7 cells and IMR-32 neuroblastoma cells were cultured in DMEM medium (Gibco) supplemented with 10% foetal calf serum (Autogen Bioclear, UK). IMR-32 cells stably overexpressing Brn-3aL were a kind gift of S Irshad, ICH. ND7 cells were differentiated as described previously (Lakin et al., 1995) in 50% DMEM, 50% Ham's F12 (Gibco), supplemented with 5 mg/ml transferrin, 250 ng/ml insulin, and 3.5 ng/ml sodium selenite.
Plasmid generation
GST-Brn-3a and GST-Brn-3b protein were produced from the vectors pGEX-3a and pGEX-3b (Budhram-Mahadeo et al., 1998) . GST-Brn-3a-POU and GST-Brn-3b-POU proteins were produced from the vectors pDEST15-3aPOU, pDEST15-3bPOU cloned using Gateway technology and the primers 3aPOUFor . The difference in mobility between the two isoforms present was similar to that between in vitro translated EWS-isoA and EWS-isoN proteins (lanes 1 and 2) and that between two isoforms present in SKSH-5Y cells (data not shown).
(b,c) GST pulldown assay demonstrating reduced interaction of radiolabelled EWS-isoN with GST-Brn-3a in vitro, compared with interactions of EWS-isoA (as shown in Figure 1 ). Percentages of input EWS protein bound to GST-Brn-3a were determined by phosphorimager analysis, data represent mean values from three independent experiments
Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al GGCTCAGGATCCGACGTGGATGCAGACCCG-3 0 ), and 3bPOURev (5 0 -GGGGACCACTTTGTACAAGAAAGCT-GGGTTGTCGACCTAAATGCCGGCAGAGTATTTC-3 0 ). GST-Brn-3aN protein was produced from the vector pGEX3aN subcloned from the yeast vector pBD-3aN (M Calissano, ICH) into pGEX 4T-1 (Amersham Pharmacia Biotech) using EcoRI and SalI. GST-TLS(C) protein was produced from the vector pGEX-TLS(274-525) (Uranishi et al., 2001) . GST-EWS(C) protein was produced from the vector pGEX-EWS(247-656), subcloned from pBS-EWS (STAET19/2; Plougastel et al., 1993) into pGEX 4T-1 using BamH1 and EcoRI. From pBS-EWS, pBS-EWS(1-246) was generated using EcoRI and BamHI, pBS-EWS(1-345) using EcoRI and BglII, and pBS-EWS(247-656) using BamHI and EcoRI. pBS-EWS(386-656) was generated from a positive EWS yeast-twohybrid clone (Thomas and Latchman, 2002) . Wild-type human EWSisoA protein was produced in vitro from the vector pBS-EWS, EWSisoN from the vector pBS-EWSisoN , Brn-3a from the vector pBS-3aL (Budhram-Mahadeo et al., 1998) , TLS from the vector pSG5-FL-TLS (Chansky et al., 2001) , and EWS/Fli-1 type 1 from the vector pBS-EWS/ Fli-1 (C Denny). EWS/ERG was produced from the vector pBS-EWS/ERG, subcloned from pSRa EWS/ERG (C Denny) using XbaI and HinDIII. EWS/ETV1 was produced from the vector pBS-EWS/ETV1, subcloned from pSRa EWS/ETV1 (C Denny) using XbaI and ClaI. EWS/ATF-1 was produced from the vector pBS-EWS/ATF-1, subcloned from pD287C (Li and Lee, 2000) using HinDIII and XbaI. Fli-1 was produced from pBS-Fli-1 (C Denny) and from this pBS-Fli-1(1-235) and pBSFli-1(236-452) subcloned using EcoRI and EcoRI/HinDIII, respectively. To create pSG5-FLAG-3aL, murine Brn-3a coding sequence was removed from pBS-3aL using EcoRI and BamH1 and subcloned into pSG5-FLAG (from pSG5-FLAG-TLS) at sites EcoRI and BglII. Expression of proteins from plasmids such as pJ4 containing the Moloney Murine Leukaemia Virus LTR promoter has been previously well established in ND7 cells (Morris et al., 1994) . pJ4-EWS was subcloned from pBS-EWS, pJ4-Fli-1 from pBS-Fli-1, and pJ4-EWS/Fli-1 from pBS-EWS/Fli-1. SNAP-25 (À2200) luciferase, subcloned from SNAP-25(A) CAT (Lakin et al., 1995; Ryabinin et al., 1995) , was a kind gift of S Dawson, UCL.
GST pulldown assay
This was performed generally as described previously (Budhram-Mahadeo et al., 1998) . Briefly, GST proteins were expressed in E.coli BL-21gold (Stratagene) using IPTG induction, bacteria were lysed by freezing overnight at À701C and slow thawing on ice, and GST proteins purified from lysates using glutathione beads (Amersham). In vitro translated proteins were produced in 50 ml reactions using a commercial transcription and translation kit (Promega) as per the manufacturer's protocol. After washing and preincubation with milk, approximately 2 mg GST protein (as determined by Coomassie stain) was incubated with 5 ml of in vitro translated protein for 1 h at room temp, five washes performed, and beads run on SDS-PAGE, which was then Coomassie stained, dried and exposed to autoradiography film overnight. Lysate pulldown assay was perfomed as per GST pulldown, with 100 mg whole-cell lysate replacing in vitro translated protein.
Immunoblot analysis
This was performed as described previously (Gascoyne et al., 2003) . Briefly, cells were washed twice in PBS, snap-frozen, resuspended in whole-cell lysis buffer (10 mM HEPES, 400 mM NaCl, 0.1 mM EDTA, 5% glycerol, with protease inhibitors) and incubated on ice for 20 min. For Bcl-2 analysis, lysis was performed in 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, with protease inhibitors. Protein concentration of lysates was measured by Bradford assay, and 50 mg protein was separated by SDS-PAGE. Semidry transfer was followed by blocking of the membrane in TBS (10 mM Tris pH 7.6, 150 mM NaCl) containing 4% nonfat dried milk. Antibody incubations were performed overnight at 41C in TBS containing 4% bovine serum albumin. Primary antibody concentrations were as follows; 1 : 200 (a-Bcl-2, Oncogene), 1 : 500 (a-Brn3a, Chemicon), 1 : 1000 (a-STAT-1, Santa Cruz), 1 : 1000 (a-FLAG, Sigma), 1 : 1000 (a-SNAP25, Chemicon), 1 : 500 (a-EWS, Santa Cruz), and 1 : 5000 (a-actin, Santa Cruz).
Immunoprecipitation
This was performed generally as described previously (Araya et al., 2003) . Briefly, 5 Â 10 6 cells were washed twice in ice-cold PBS, and nuclei prepared by lysis in 10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM PMSF, for 15 min on ice and subsequent addition of NP-40 to 0.6%. After brief centrifugation, nuclei were lysed in 20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF for 15 min at 41C and centrifuged 5 min at 41C to obtain nuclear lysate. Lysate (200 ml) was diluted with 300 ml binding buffer (5 mM NaF, 20 mM HEPES pH 7.9, 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, 5% glycerol) and incubated for 12-16 h at 41C with 30 ml agarose-conjugated anti-FLAG antibody (Sigma). Immune complexes were washed twice in binding buffer and eluted from agarose beads by boiling in SDS loading dye without dithiothreitol or b-mercaptoethanol. A volume of 1 ml of b-mercaptoethanol was added per tube and the samples were boiled again to dissociate protein complexes before SDS-PAGE analysis.
Transient transfection assay
For luciferase and TUNEL studies, 50 000 cells were plated per well in 24-well plates 24 h prior to transfection. At 2 h prior to transfection, medium was changed to DMEM containing 5% foetal bovine serum (Sigma). In all, 1 mg DNA per well was diluted to 58.3 ml with H 2 0, 8.3 ml 2 M CaCl 2 was added, then 66.7 ml 2 Â HBS (0.27 M NaCl, 10 mM KCl, 1.44 mM Na 2 HPO 4 , 11mM glucose and 42 mM HEPES) was added while vortexing. Precipitate was added to each well immediately. The medium was changed to L15 containing 5% serum after 4 h, and cells were harvested 36 h later. Routinely, 0.5 mg reporter plasmid plus 0.25 mg each expression plasmid was transfected per well, with 10 ng of pRL-TK (Promega) added to enable measurement of Renilla luciferase activity and therefore transfection efficiency. For FACS, immunoblot and neurite outgrowth experiments, 100 000 cells per well in six-well plates were transfected with 5 mg expression vector (including 2 mg pEGFP-C1 vector if necessary) by the above method. COS-7 cells were transfected using the same method with 10 mg pSG5-FLAG3aL per 10 cm plate.
Statistical analyses
Transfection data represent the mean values from three independent experiments. FACS data represent results from two independent experiments each performed in duplicate with 10 000 GFP-positive cells analysed per sample. Neurite outgrowth experiments were performed Select Brn-3a functions regulated by EWS/Fli-1 DM Gascoyne et al three times, each in duplicate, with at least 500 GFP-positive cells being scored per well. TUNEL experiments were performed three times, with duplicates in each experiment, again at least 500 GFP-positive cells were analysed per well. Error bars represent standard deviation of means. The Pvalues were obtained using Student's t-test with equal variance not assumed.
